Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2261-2012Class II

Visual-ICE Cryoablation System, Model FPRCH 6000

Galil Medical Ltd. / initiated 2012-07-20 / Terminated / root cause: design

Galil Medical, Inc. began a recall of Visual-ICE Cryoablation System, Model FPRCH 6000 Product Usage: The Galil Medical Visual-ICE Cryoablation System is intended for cryoablative destruction of... on . FDA classified it as Class II and gives the reason as "Galil Medical is recalling a number of Visual Ice Cryoablation Systems because the gas regulators may fail to regulate the gas pressure, rendering the devices inoperable". As of , the recall status on record is Terminated, and MDM tags the root cause as design.

Recall record

Recall number
Z-2261-2012
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Galil Medical Ltd.
Product
Visual-ICE Cryoablation System, Model FPRCH 6000 Product Usage: The Galil Medical Visual-ICE Cryoablation System is intended for cryoablative destruction of tissue during minimally invasive procedures; various Galil Medical accessory products are required to perform these procedures. The Visual-ICE System is indicated for use as a cryosurgical tool in the fields of general surgery, dermatology, neurology (including cryoanalgesia), thoracic surgery, ENT, gynecology, oncology, proctology, and urology. This system is designed to destroy tissue (including prostate and kidney tissue, liver metastases, tumors, skin lesions, and warts) by the application of extremely cold temperatures.
Product code
GEH Unit, Cryosurgical, Accessories
Reason for recall
Galil Medical is recalling a number of Visual Ice Cryoablation Systems because the gas regulators may fail to regulate the gas pressure, rendering the devices inoperable.
Root cause tag
design
FDA root cause
Device Design
Action
Galil Medical sent a "Voluntary Medical Device Field Correction" letter dated July 20, 2012, via UPS to all affected customers. The letter identified the affected product, problem and actions to be taken. The letter states that a Galil Field Service team will be contacting customers to schedule a service visit the week of July 23rd. Customers were instructed to forward and communicate this field correction notice and instructions to individuals in their organization and/or to other organizations affected by this action. For questions call Galil Medical Customer Service.
Quantity in commerce
4
Distribution
Worldwide Distribution - US nationwide including the state of MN and the countries of United Kingdom and Netherlands
Product codes and lots
VL0004 VL0014 VL0015 VL0016

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2261-2012
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2261-2012Class IITerminatedVoluntary: Firm initiated